Evidence map›Paper›PMID 15124012›Full record

ArticleThe Journal of clinical investigation2004

Lost in transdifferentiation.

Mark H Hoofnagle, Brian R Wamhoff, Gary K Owens

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Genetic silencing of KChannels (Austin, Tex.) · 2025
    Article
  2. Article
  3. TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.Cold Spring Harbor perspectives in biology · 2017
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. MicroRNAs in Vascular Biology.International journal of vascular medicine · 2012
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mark H HoofnagleDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia 22908, USA.
Brian R Wamhoff
Gary K Owens
University of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What are the true origins of the smooth muscle cells (SMCs) present in the intimal lesions of transplant arteriosclerosis? A new study in the JCI shows that Sca-1(+) cells purified from the mouse aortic root can migrate through an irradiated vein graft to the neointima of the vessel and transdifferentiate to express the early SMC differentiation marker gene SM22. Do Sca-1(+) cells transdifferentiate into SMC-like cells, or is activation of SMC marker genes a consequence of fusion of these cells with preexisting SMCs, a possibility raised by results of studies of adult stem cells in animal models of liver regeneration ? Or could this be bona fide transdifferentiation that recapitulates the pathologic processes in humans?

Indexed as

Cell DifferentiationAnimalsAortaArteriosclerosisBone Marrow CellsCell FusionCell LineageCell MovementCells, CulturedDisease Models, AnimalGenetic MarkersHematopoietic Stem CellsHumansMiceMice, TransgenicModels, BiologicalGenetic MarkersMuscle Proteins

Identifiers

PMID15124012
PMCPMC398438
OpenAlexW2144797665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.